Trump Kills Drug Rebate ‘Safe Harbor’ Rule That Favored Pharma (5)

The Trump administration reversed course on a proposed rule to end the rebates that drug manufacturers pay to pharmacy liaisons.

The rule had been heavily lobbied for by pharmaceutical companies, a move that backfired and contributed to the decision to stop moving forward with the rule, according to two sources briefed on the discussions. The Pharmaceutical Research and Manufacturers of America (PhRMA) told the government in April that it supports the proposal to change the rebate system and considers the changes “too important to delay.”

The trade group also launched an ad campaign in support of the rule.

“Based on ...